Open Access Article
This Open Access Article is licensed under a Creative Commons Attribution 3.0 Unported Licence
Correction: Injectable postoperative enzyme-responsive hydrogels for reversing temozolomide resistance and reducing local recurrence after glioma operation
Zongren
Zhao†
ab,
Jiawei
Shen†
ac,
Long
Zhang†
a,
Lansheng
Wang
a,
Haoyue
Xu
a,
Yuhan
Han
a,
Jun
Jia
a,
Yang
Lu
a,
Rutong
Yu
*ab and
Hongmei
Liu
*ab
aInstitute of Nervous System Diseases, Xuzhou Medical University, Xuzhou 221002, P. R. China. E-mail: liuhongmei816@sina.com; yu.rutong@163.com; Tel: +86 17716228111
bDepartment of Neurosurgery, Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, P. R. China
cDepartment of Neurosurgery, The Second Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, P. R. China
First published on 8th July 2020
Abstract
Correction for ‘Injectable postoperative enzyme-responsive hydrogels for reversing temozolomide resistance and reducing local recurrence after glioma operation’ by Zongren Zhao et al., Biomater. Sci., 2020, DOI: 10.1039/d0bm00338g.
The authors regret incorrect affiliations in the original manuscript. The corrected list of affiliations is as shown in this Correction article.
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
Footnote |
| † These authors contributed equally to this work. |
| This journal is © The Royal Society of Chemistry 2020 |